HomeStock ScreenerFraser & CompanyIntrinsic Value

Fraser & Company Intrinsic Value

Fraser & Company (FRASER) median intrinsic value is ₹6.25 from 1 valuation models (range ₹6–₹6), vs current price ₹9.45 — -33.9% downside (Trading Above Calculated Value), margin of safety -51.2%. For current market price and key ratios, visit Fraser & Company screener.

Market Price (CMP)
₹9.45
Primary Intrinsic Value
₹6.25
Market Cap
₹7.6 Cr
-33.9% Downside
Median Value
₹6.25
Value Range
₹6 - ₹6
Assessment
Trading Above Calculated Value
Safety Margin
-51.2%

FRASER Valuation Methods Summary — DCF, Graham Number & P/E

Fraser & Company intrinsic value across 1 models vs current price ₹9.45 — upside/downside and value range per method. Read FRASER dividend history for the complete payout history and dividend yield track record.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹6.25 ₹5.62 - ₹6.88 -33.9% Book Value/Share: ₹6.25, P/B: 1.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

FRASER Intrinsic Value vs Market Price — All Valuation Models

Fraser & Company fair value range ₹6–₹6 vs current market price ₹9.45 across 1 valuation models. Analyse Fraser & Company ownership pattern to track promoter, FII and institutional holdings.

FRASER Intrinsic Value Analysis — Undervalued or Overvalued?

Fraser & Company median intrinsic value ₹6.25, current price ₹9.45 — Trading Above Calculated Value by 33.9%, margin of safety -51.2%.

What is the intrinsic value of FRASER?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Fraser & Company (FRASER) is ₹6.25 (median value). With the current market price of ₹9.45, this represents a -33.9% variance from our estimated fair value.

The valuation range spans from ₹6.25 to ₹6.25, indicating ₹6.25 - ₹6.25.

Is FRASER undervalued or overvalued?

Based on our multi-method analysis, Fraser & Company (FRASER) appears to be trading above calculated value by approximately 33.9%.

FRASER Financial Health — Key Ratios vs Industry Benchmarks

Fraser & Company financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 10.00 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 2.60 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity -20.0% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency

FRASER Cash Flow Quality — Operating & Free Cash Flow

Fraser & Company operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹-1 Cr ₹-1 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹-2 Cr ₹-2 Cr Negative Cash Flow 3/10
March 2021 ₹3 Cr ₹2 Cr Positive Free Cash Flow 8/10